UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Why Index Weight Matters discusses the real-world effects of weighting choices on benchmarks and portfolio behavior.
21,890 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
February data show a 9% month-over-month rise in rate-lock volume as lower borrowing costs draw buyers back. Purchase...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
A major alliance links Polymarket with Palantir and TWG AI to upgrade prediction markets with cutting-edge AI. Learn ...
Oil-driven volatility keeps the S&P 500 near unchanged on March 11, 2026, as traders weigh supply risks and central-b...
In 2026, AI budgets surge while pilots fade. A four‑pillar playbook separates winners from the rest, focusing on data...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
Lumentum says its backlog extends through 2027, signaling a sustained AI-driven demand boom for optical components. N...
Smith Douglas Homes bucked the public-builder slowdown by accelerating volume even as margins contract. The Woodstock...
Federal officials order a Texas-based oil company to resume offshore California production under the Defense Producti...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...